Pedro Beltran insider trades
Open-market stock purchases and sales by Pedro Beltran, President and CEO at BridgeBio Oncology Therapeutics, Inc, from SEC Form 4 filings since Aug 26, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 1, 2026 | BBOT BridgeBio Oncology Therapeutics, Inc | Sold (not open market) | $4.1K |
| Jul 1, 2026 | BBOT BridgeBio Oncology Therapeutics, Inc | Sold (not open market) | $8.2K |
| May 10, 2026 | BBOT BridgeBio Oncology Therapeutics, Inc | Bought (not open market) | — |
| Apr 1, 2026 | BBOT BridgeBio Oncology Therapeutics, Inc | Sold (not open market) | $9.5K |
| Mar 10, 2026 | BBOT BridgeBio Oncology Therapeutics, Inc | Bought (not open market) | — |
| Mar 10, 2026 | BBOT BridgeBio Oncology Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- BBOT BridgeBio Oncology Therapeutics, Inc: other filings, last Oct 1, 2026